Simvastatin and Hyperuricaemia - a phase IV clinical study of FDA data

Summary:

Hyperuricaemia is reported as a side effect among people who take Simvastatin (simvastatin), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Allopurinol, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Hyperuricaemia when taking Simvastatin. It is created by eHealthMe based on reports of 249,370 people who have side effects when taking Simvastatin from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.

What is Hyperuricaemia?

Hyperuricaemia (level of uric acid in the blood that is abnormally high) is found to be associated with 701 drugs and 791 conditions by eHealthMe. Check the latest studies of Hyperuricaemia.

On Jul, 17, 2026

249,370 people reported to have side effects when taking Simvastatin.
Among them, 139 people (0.06%) have Hyperuricaemia.

Among these 139 people:

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and have Hyperuricaemia?

- Check whether Hyperuricaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simvastatin:

Simvastatin (256,969 reports)

Hyperuricaemia treatments and more:

Hyperuricaemia (25,670 reports)

How severe was Hyperuricaemia and when was it recovered:

Hyperuricaemia in Simvastatin

Expand to all the drugs that have ingredients of simvastatin:

Hyperuricaemia and drugs with ingredients of simvastatin (169 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperuricaemia:

Hyperuricaemia (701 drugs)

Browse all the conditions that are associated with Hyperuricaemia:

Hyperuricaemia (791 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.